Compare RFL & ICMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | RFL | ICMB |
|---|---|---|
| Founded | 2017 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Finance: Consumer Services |
| Sector | Finance | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 92.6M | 17.2M |
| IPO Year | 2017 | 2013 |
| Metric | RFL | ICMB |
|---|---|---|
| Price | $3.38 | $1.17 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 295.8K | 72.6K |
| Earning Date | 06-10-2026 | 05-13-2026 |
| Dividend Yield | N/A | ★ 21.74% |
| EPS Growth | ★ 28.28 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $917,000.00 | N/A |
| Revenue This Year | N/A | $7.43 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 43.96 | N/A |
| 52 Week Low | $1.12 | $0.99 |
| 52 Week High | $3.17 | $3.12 |
| Indicator | RFL | ICMB |
|---|---|---|
| Relative Strength Index (RSI) | 82.61 | 40.11 |
| Support Level | $1.22 | $0.99 |
| Resistance Level | N/A | $3.03 |
| Average True Range (ATR) | 0.35 | 0.05 |
| MACD | 0.08 | 0.02 |
| Stochastic Oscillator | 92.66 | 12.50 |
Rafael Holdings Inc is a biotechnology firm that develops pharmaceuticals and invests in clinical and early-stage companies in pharmaceuticals and medical devices. Trappsol Cyclo is in Phase 3 trials for Niemann-Pick Disease Type C1. The company focuses on completing these trials, seeking regulatory approval, and commercializing the product. It also invests in portfolio companies including Cyclo, LipoMedix, Barer, Rafael Medical Devices, Cornerstone, and Day Three, targeting therapeutics for unmet medical needs. The business operates through three segments: Healthcare, Infusion Technology, and Real Estate. Operations are based in the United States and Israel.
Investcorp Credit Management BDC Inc is an externally managed, non-diversified closed-end management investment firm that has elected to be regulated as a business development company (BDC). The investment objective of the company is to maximize total return to stockholders in the form of current income and capital appreciation by investing in debt and related equity of privately held lower middle-market companies. The company principally invests in the debt of middle-market companies, which it defines as those companies that have an enterprise value.